Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Impact of Anticoagulant and Antiplatelet on the Thrombotic Risk in Cancer Associated Thrombosis

Shaker A Mousa, PhD BPharm, MBA, MSc, Kavitha Godugu, PhD, Noureldien Hassan Elsayed Darwish, MDPhDBS, Sharan Krishnappan, Anjali Bhave

Blood (2019) 134 (Supplement_1): 3677.

https://doi.org/10.1182/blood-2019-130426

Published: 2019

Journal Articles

Antiplatelet Glycoprotein Antibodies Profile in Adult Patients with Primary Immune Thrombocytopenia and the Comparison with Regards to the Treatment Response to Corticosteroids

Tubagus Djumhana Atmakusuma, MDPhD, Lugyanti Sukrisman, MDPhD, Fransiska Hardi, MD Internist

Blood (2015) 126 (23): 4653.

https://doi.org/10.1182/blood.V126.23.4653.4653

Published: 2015

Journal Articles

Diagnostic Yield Of Serologic Evaluation For Neonatal Alloimmune Thrombocytopenia (NAIT) In Cases With Fetal Abnormalities Without Documented Thrombocytopenia

Janice G McFarland, MD, James B Bussel, MD, Richard H. Aster, MD, Brian R Curtis, PhD, D(ABMLI)

Blood (2013) 122 (21): 3660.

https://doi.org/10.1182/blood.V122.21.3660.3660

Published: 2013

Journal Articles

Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?

Jan David Hohmann, Xiaowei Wang, Stefanie Krajewski, Carly Selan, Carolyn A. Haller, Andreas Straub, Elliot L. Chaikof, Harshal H. Nandurkar, Christoph E. Hagemeyer, Karlheinz Peter

Blood (2013) 121 (16): 3067–3075.

https://doi.org/10.1182/blood-2012-08-449694

Published: 2013

Includes: Supplemental data

Journal Articles

Reversal of Glanzmann's Thrombasthenia & Glycoprotein IIb/Iiia Antagonists by Combined Haemostatic Intervention with Fibrinogen Concentrate and Recombinant Factor VIIa.

Gayathri Murali-Krishnan, BSc, MSc, David Bevan, Consultant, Aine McCormick, Ph.D., Savita Rangarajan, MBBS, FRCP, FRCPath, Benny Sørensen, MD, Ph.D.

Blood (2009) 114 (22): 1325.

https://doi.org/10.1182/blood.V114.22.1325.1325

Published: 2009

Journal Articles

Platelet Mitochondrial Potential and Function Is Altered During Severe Septic Shock.

Andrea Artoni, MD, Alessandro Protti, MD, Anna Lecchi, BSC, Giovanna Motta, BSC, Francesca Rosini, MD, Monica Savioli, MD, Maria Luisa Caspani, MD, Pier Mannuccio Mannucci, MD

Blood (2009) 114 (22): 5074.

https://doi.org/10.1182/blood.V114.22.5074.5074

Published: 2009

Journal Articles

Platelet Tissue Factor: Fast and Specific Clotting Activation Pathway Mediated by VWF-GPIba Interaction and Platelet Membrane FVII. Human Platelets Contain All the Components for Assembling the Prothrombinase Complex and Their Procoagulant Function Is Independent of Aggregation/Secretion and GPVI Function.

Olga Panes, Valeria Matus, PhD, Claudia G. Sáaez, PhD, Jaime Pereira, MD, Diego Mezzano, MD

Blood (2009) 114 (22): 3000.

https://doi.org/10.1182/blood.V114.22.3000.3000

Published: 2009

Journal Articles

Mutation Screening of GPIIb and GPIIIa Exons by Conformation Sensitive Gel Electrophoresis.

Meganathan Kannan, MSc, Firdos Ahmad, M.Sc, Birendra K. Yadav, M.Sc, Rajive Kumar, MD, Renu Saxena, MD

Blood (2007) 110 (11): 3218.

https://doi.org/10.1182/blood.V110.11.3218.3218

Published: 2007

Journal Articles

Eradication of Helicobacter pylori Shifts the Balance of Fcγ Receptors on Monocytes toward the Inhibitory FcγRIIB in Patients with Chronic ITP.

Masataka Kuwana, MD, PhD, Atsuko Asahi, MD, Hidekazu Suzuki, MD, PhD, Yuka Okazaki, Yasuo Ikeda, MD

Blood (2006) 108 (11): 1082.

https://doi.org/10.1182/blood.V108.11.1082.1082

Published: 2006

Journal Articles

Constitutive Activation of Hemostasis in Children with Sickle Cell Disease.

MacGregor Steele, MD, Suzan Williams, MD, Fred Pluthero, PhD, K.W. Annie Bang, Ran Goldman, MD, Jeremy Friedman, MD, John Freedman, MD, Melanie Kirby, MD, Margaret L. Rand, PhD, Victor S. Blanchette, FRCP, Walter H. Kahr, MD,PhD

Blood (2006) 108 (11): 1216.

https://doi.org/10.1182/blood.V108.11.1216.1216

Published: 2006

Journal Articles

Association between Platelet Autoantibody Specificity and Response to Intravenous Immunoglobulin G in the Treatment of Patients with Immune Thrombocytopenia.

Kaye L. Johnston, PA-C, Ronald S. Go, MD

Blood (2006) 108 (11): 3987.

https://doi.org/10.1182/blood.V108.11.3987.3987

Published: 2006

Journal Articles

Novel Single Agents with Combined Anti-Coagulant and Anti-Platelet Activities: Potential Treatment Option for the Management of HIT.

Jeanine M. Walenga, PhD, Margaret Prechel, PhD, Walter P. Jeske, PhD, Meredith K. McDonald, BS, James M. Daikur, BS, Wasimul Haque, PhD

Blood (2005) 106 (11): 1884.

https://doi.org/10.1182/blood.V106.11.1884.1884

Published: 2005

Journal Articles

Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways

Robert T. Dorsam, Soochong Kim, Swaminathan Murugappan, Swathi Rachoor, Haripriya Shankar, Jianguo Jin, Satya P. Kunapuli

Blood (2005) 105 (7): 2749–2756.

https://doi.org/10.1182/blood-2004-07-2821

Published: 2005

Journal Articles

Thrombocytopenia following treatment with platelet glycoprotein IIb/IIIa inhibitors

Constantinos G. Christopoulos

Blood (2003) 101 (4): 1655.

https://doi.org/10.1182/blood-2002-10-3077

Published: 2003

Journal Articles

Glycoprotein IIb Leu214Pro Mutation Produces Glanzmann Thrombasthenia With Both Quantitative and Qualitative Abnormalities in GPIIb/IIIa

Christine M. Grimaldi, Fangping Chen, Changhong Wu, Harvey J. Weiss, Barry S. Coller, Deborah L. French

Blood (1998) 91 (5): 1562–1571.

https://doi.org/10.1182/blood.V91.5.1562

Published: 1998

Journal Articles

7E3 F(ab′) 2 , a Monoclonal Antibody to the Platelet GPIIb/IIIa Receptor, Protects Against Microangiopathic Hemolytic Anemia and Microvascular Thrombotic Renal Failure in Baboons Treated With C4b Binding Protein and a Sublethal Infusion of Escherichia coli

F.B. Taylor, B.S. Coller, A.C.K. Chang, G. Peer, R. Jordan, W. Engellener, C.T. Esmon

Blood (1997) 89 (11): 4078–4084.

https://doi.org/10.1182/blood.V89.11.4078

Published: 1997

Journal Articles

Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg- Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model

Y Imura, JM Stassen, S Bunting, F Stockmans, D Collen

Blood (1992) 80 (5): 1247–1253.

https://doi.org/10.1182/blood.V80.5.1247.1247

Published: 1992

NARROW

Impact of Anticoagulant and Antiplatelet on the Thrombotic Risk in Cancer Associated Thrombosis

Antiplatelet Glycoprotein Antibodies Profile in Adult Patients with Primary Immune Thrombocytopenia and the Comparison with Regards to the Treatment Response to Corticosteroids

Diagnostic Yield Of Serologic Evaluation For Neonatal Alloimmune Thrombocytopenia (NAIT) In Cases With Fetal Abnormalities Without Documented Thrombocytopenia

Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?

Reversal of Glanzmann's Thrombasthenia & Glycoprotein IIb/Iiia Antagonists by Combined Haemostatic Intervention with Fibrinogen Concentrate and Recombinant Factor VIIa.

Platelet Mitochondrial Potential and Function Is Altered During Severe Septic Shock.

Mutation Screening of GPIIb and GPIIIa Exons by Conformation Sensitive Gel Electrophoresis.

Eradication of Helicobacter pylori Shifts the Balance of Fcγ Receptors on Monocytes toward the Inhibitory FcγRIIB in Patients with Chronic ITP.

Constitutive Activation of Hemostasis in Children with Sickle Cell Disease.

Association between Platelet Autoantibody Specificity and Response to Intravenous Immunoglobulin G in the Treatment of Patients with Immune Thrombocytopenia.

Novel Single Agents with Combined Anti-Coagulant and Anti-Platelet Activities: Potential Treatment Option for the Management of HIT.

Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways

Thrombocytopenia following treatment with platelet glycoprotein IIb/IIIa inhibitors

Glycoprotein IIb Leu214Pro Mutation Produces Glanzmann Thrombasthenia With Both Quantitative and Qualitative Abnormalities in GPIIb/IIIa

7E3 F(ab′) 2 , a Monoclonal Antibody to the Platelet GPIIb/IIIa Receptor, Protects Against Microangiopathic Hemolytic Anemia and Microvascular Thrombotic Renal Failure in Baboons Treated With C4b Binding Protein and a Sublethal Infusion of Escherichia coli

Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg- Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only